Holen Sie sich die Stockscreener-App
0.388
2.83%
-0.0113
Handel nachbörslich:
.38
-0.008
-2.06%
Schlusskurs vom Vortag:
$0.3993
Offen:
$0.3993
24-Stunden-Volumen:
145.67K
Relative Volume:
0.10
Marktkapitalisierung:
$5.44M
Einnahmen:
$294.20K
Nettoeinkommen (Verlust:
$-12.25M
KGV:
-0.0705
EPS:
-5.5
Netto-Cashflow:
$-10.77M
1W Leistung:
-9.15%
1M Leistung:
+2.08%
6M Leistung:
-3.24%
1J Leistung:
-76.20%
1-Tages-Spanne:
$0.3812
$0.3995
1-Wochen-Bereich:
$0.3692
$0.432
52-Wochen-Spanne:
$0.2375
$2.3499
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Vergleichen Sie AEMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AEMD | 0.388 | 5.44M | 294.20K | -12.25M | -10.77M | -5.50 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Medical Device Network
Aethlon Medical Launches Breakthrough Cancer Trial for Hemopurifier® Treatment | AEMD Stock News - StockTitan
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (AEMD) Sets Q2 2024 Earnings Release for November 13 | AEMD Stock News - StockTitan
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Is Aethlon Medical Inc (AEMD) worth investing in despite its overvalued state? - US Post News
Daily Progress: Aethlon Medical Inc (AEMD) Gain 1.15, Closing at 0.40 - The Dwinnex
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... - Yahoo Finance
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - cnhinews.com
A new trading data show Aethlon Medical Inc (AEMD) is showing positive returns. - SETE News
Deeper Dive: Understanding Aethlon Medical Inc (AEMD) Through its Various Ratios - The Dwinnex
Aethlon Medical names James Frakes permanent CEO By Investing.com - Investing.com Canada
Aethlon Medical names James Frakes permanent CEO - Investing.com
Aethlon Medical Appoints James B. Frakes as CEO - TipRanks
Aethlon Medical Expands Equity Incentive Plan by 3 Million shares - Investing.com Canada
Examining Aethlon Medical Inc (AEMD) stock is warranted - US Post News
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Analysts’ New Coverage for September 29th (AEMD, AEZS, AWX, BGCP, BGI, BLPH, BPTH, CAC, CALA, CBFV) - Defense World
AEMD: Positive Takeaways from Life Science Investor Forum Presentation - Zacks Small Cap Research
Analysts’ New Coverage for September 21st (AEMD, AEZS, AWX, BGCP, BLPH, BPTH, CAC, CALA, CBFV, CCM) - Defense World
Quarterly Metrics: Quick and Current Ratios for Aethlon Medical Inc (AEMD) - The Dwinnex
AEMD’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Market cap of Aethlon Medical Inc [AEMD] reaches 5.44M – now what? - The DBT News
Aethlon Hemopurifier study receives ethics approval in India By Investing.com - Investing.com Nigeria
A look at AEMD’s current quarter earnings estimates - US Post News
Aethlon Hemopurifier study receives ethics approval in India - Investing.com
Immunotherapy Clinical TrialsA New Approach to Treating Cancer - StockTitan
Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India - StockTitan
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September - Investorideas.com newswire
Aethlon Medical to Present at Virtual Investor Conferences in September - StockTitan
Innovation Driving Cancer's Solid Tumors Market - StockTitan
Aethlon Gains on Product News - Baystreet.ca
Aethlon begins patient enrollment in Hemopurifier cancer trial - Investing.com
Aethlon begins patient enrollment in Hemopurifier cancer trial By Investing.com - Investing.com UK
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial - StockTitan
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th - ForexTV.com
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):